| Acute coronary syndromes BA Bergmark, N Mathenge, PA Merlini, MB Lawrence-Wright, ... The Lancet 399 (10332), 1347-1358, 2022 | 347 | 2022 |
| Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis MS Sabatine, BA Bergmark, SA Murphy, P T O'Gara, PK Smith, ... The Lancet 398 (10318), 2247-2257, 2021 | 216 | 2021 |
| Fat embolism syndrome E Kosova, B Bergmark, G Piazza Circulation 131 (3), 317-320, 2015 | 173 | 2015 |
| Effect of vupanorsen on non–high-density lipoprotein cholesterol levels in statin-treated patients with elevated cholesterol: TRANSLATE-TIMI 70 BA Bergmark, NA Marston, CR Bramson, M Curto, V Ramos, A Jevne, ... Circulation 145 (18), 1377-1386, 2022 | 149 | 2022 |
| Understanding suicide and disability through three major disabling conditions: Intellectual disability, spinal cord injury, and multiple sclerosis MJ Giannini, B Bergmark, S Kreshover, E Elias, C Plummer, E O'Keefe Disability and health journal 3 (2), 74-78, 2010 | 123 | 2010 |
| Initial findings from the North American COVID-19 myocardial infarction registry S Garcia, P Dehghani, C Grines, L Davidson, KR Nayak, J Saw, ... Journal of the American College of Cardiology 77 (16), 1994-2003, 2021 | 111 | 2021 |
| An exploratory analysis of proprotein convertase subtilisin/kexin type 9 inhibition and aortic stenosis in the FOURIER trial BA Bergmark, ML O’Donoghue, SA Murphy, JF Kuder, MV Ezhov, ... JAMA cardiology 5 (6), 709-713, 2020 | 110 | 2020 |
| Diagnostic and prognostic value of myocardial blood flow quantification as non-invasive indicator of cardiac allograft vasculopathy PE Bravo, BA Bergmark, T Vita, VR Taqueti, A Gupta, S Seidelmann, ... European heart journal 39 (4), 316-323, 2018 | 102 | 2018 |
| Metformin use and clinical outcomes among patients with diabetes mellitus with or without heart failure or kidney dysfunction: observations from the SAVOR-TIMI 53 trial BA Bergmark, DL Bhatt, DK McGuire, A Cahn, O Mosenzon, PG Steg, ... Circulation 140 (12), 1004-1014, 2019 | 81 | 2019 |
| US medical specialty global health training and the global burden of disease VB Kerry, RP Walensky, AC Tsai, RW Bergmark, BA Bergmark, C Rouse, ... Journal of Global Health 3 (2), 020406, 2013 | 71 | 2013 |
| Olezarsen for hypertriglyceridemia in patients at high cardiovascular risk BA Bergmark, NA Marston, TA Prohaska, VJ Alexander, A Zimerman, ... New England Journal of Medicine 390 (19), 1770-1780, 2024 | 70 | 2024 |
| Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular risk BA Bergmark, BM Scirica, PG Steg, CL Fanola, Y Gurmu, O Mosenzon, ... European heart journal 39 (24), 2255-2262, 2018 | 62 | 2018 |
| Klotho, fibroblast growth factor‐23, and the renin–angiotensin system—an analysis from the PEACE trial BA Bergmark, JA Udell, DA Morrow, P Jarolim, JF Kuder, SD Solomon, ... European journal of heart failure 21 (4), 462-470, 2019 | 56 | 2019 |
| Association of fibroblast growth factor 23 with recurrent cardiovascular events in patients after an acute coronary syndrome: a secondary analysis of a randomized clinical trial BA Bergmark, JA Udell, DA Morrow, CP Cannon, DL Steen, P Jarolim, ... JAMA cardiology 3 (6), 473-480, 2018 | 50 | 2018 |
| Early aspirin use and the development of cardiac allograft vasculopathy M Kim, BA Bergmark, TA Zelniker, MR Mehra, GC Stewart, DS Page, ... The Journal of Heart and Lung Transplantation 36 (12), 1344-1349, 2017 | 46 | 2017 |
| Baseline adiponectin concentration and clinical outcomes among patients with diabetes and recent acute coronary syndrome in the EXAMINE trial BA Bergmark, CP Cannon, WB White, P Jarolim, Y Liu, MP Bonaca, ... Diabetes, Obesity and Metabolism 19 (7), 962-969, 2017 | 42 | 2017 |
| The Surgeon General’s call to action to improve the health and wellness of persons with disabilities: Historical review, rationale, and implications 5 years after publication RH Carmona, M Giannini, B Bergmark, J Cabe Disability and health journal 3 (4), 229-232, 2010 | 39 | 2010 |
| Effect of evolocumab on acute arterial events across all vascular territories: results from the FOURIER trial K Oyama, RP Giugliano, M Tang, MP Bonaca, JL Saver, SA Murphy, ... European Heart Journal 42 (47), 4821-4829, 2021 | 37 | 2021 |
| Effect of evolocumab on complex coronary disease requiring revascularization K Oyama, RHM Furtado, A Fagundes Jr, TA Zelniker, M Tang, J Kuder, ... Journal of the American College of Cardiology 77 (3), 259-267, 2021 | 35 | 2021 |
| Nonculprit lesion myocardial infarction following percutaneous coronary intervention in patients with acute coronary syndrome BM Scirica, BA Bergmark, DA Morrow, EM Antman, MP Bonaca, ... Journal of the American College of Cardiology 75 (10), 1095-1106, 2020 | 33 | 2020 |
